Pub Date : 2009-06-02DOI: 10.1080/17523280902932656
Alison K. Gunn, D. Rickwood
Background: Increasingly, the use of amphetamine-type stimulants (ATS) has been associated with psychopathology, cognitive deficits, and aggression. These are important co-morbidities that need to be considered, particularly in residential drug treatments. Aims: This study compared levels of aggression, psychopathology, and executive function between participants identified as being ATS or non-ATS users who were residents within Drug Therapeutic Communities (DTCs). Method: A sample of 67 males and 37 females, aged 19–60 years, undertaking residential treatment at one of four DTCs, completed a self-report questionnaire. Participants were grouped as sustained and recent ATS use (n = 51) or prior and no ATS use (n = 53). Results: Psychopathology and executive dysfunction were high among all participants. ATS users exhibited significantly higher levels of depression, executive dysfunction, and aggression compared to non-ATS users, and these measures were highly intercorrelated. Younger age was weakly associat...
{"title":"The effect of amphetamine type stimulants on psychopathology, aggression and cognitive function among clients within a drug therapeutic community","authors":"Alison K. Gunn, D. Rickwood","doi":"10.1080/17523280902932656","DOIUrl":"https://doi.org/10.1080/17523280902932656","url":null,"abstract":"Background: Increasingly, the use of amphetamine-type stimulants (ATS) has been associated with psychopathology, cognitive deficits, and aggression. These are important co-morbidities that need to be considered, particularly in residential drug treatments. Aims: This study compared levels of aggression, psychopathology, and executive function between participants identified as being ATS or non-ATS users who were residents within Drug Therapeutic Communities (DTCs). Method: A sample of 67 males and 37 females, aged 19–60 years, undertaking residential treatment at one of four DTCs, completed a self-report questionnaire. Participants were grouped as sustained and recent ATS use (n = 51) or prior and no ATS use (n = 53). Results: Psychopathology and executive dysfunction were high among all participants. ATS users exhibited significantly higher levels of depression, executive dysfunction, and aggression compared to non-ATS users, and these measures were highly intercorrelated. Younger age was weakly associat...","PeriodicalId":88592,"journal":{"name":"Mental health and substance use : dual diagnosis","volume":"2 1","pages":"120-129"},"PeriodicalIF":0.0,"publicationDate":"2009-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78225297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2009-06-02DOI: 10.1080/17523280902930122
R. Rossiter, J. Black
The challenges encountered within public mental health services in New South Wales, Australia, have been well described in recent review documents. New South Wales and Federal government policies clearly outline expectations of evidence-based service delivery. Achieving these expectations in urban settings remains a somewhat haphazard process, while service delivery in rural and remote areas often falls markedly short of satisfactory. This article describes the almost overwhelming challenges encountered by a mental health team and drug and alcohol service confronted with a consumer with co-morbid borderline personality disorder (BPD) and a multiple substance abuse disorder. While successful evidence-based treatments for BPD have been described in the literature, therapeutic pessimism remains pervasive in many settings. When a consumer presents with a co-morbid substance abuse disorder, clinicians from both mental health and Drug and Alcohol services at times struggle to develop an effective and collaborat...
{"title":"Challenging therapeutic pessimism: borderline personality disorder and co-morbid substance abuse1","authors":"R. Rossiter, J. Black","doi":"10.1080/17523280902930122","DOIUrl":"https://doi.org/10.1080/17523280902930122","url":null,"abstract":"The challenges encountered within public mental health services in New South Wales, Australia, have been well described in recent review documents. New South Wales and Federal government policies clearly outline expectations of evidence-based service delivery. Achieving these expectations in urban settings remains a somewhat haphazard process, while service delivery in rural and remote areas often falls markedly short of satisfactory. This article describes the almost overwhelming challenges encountered by a mental health team and drug and alcohol service confronted with a consumer with co-morbid borderline personality disorder (BPD) and a multiple substance abuse disorder. While successful evidence-based treatments for BPD have been described in the literature, therapeutic pessimism remains pervasive in many settings. When a consumer presents with a co-morbid substance abuse disorder, clinicians from both mental health and Drug and Alcohol services at times struggle to develop an effective and collaborat...","PeriodicalId":88592,"journal":{"name":"Mental health and substance use : dual diagnosis","volume":"1 1","pages":"140-153"},"PeriodicalIF":0.0,"publicationDate":"2009-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83173895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2009-06-02DOI: 10.1080/17523280902932649
A. V. Wamel, H. Kroon, S. V. Rooijen
Background: In the Netherlands, mental illness and addiction are treated separately. This causes problems when treating dual disorders. There is growing consensus in the Netherlands that the integration of mental health care and addiction care may be the best way to treat dual disorder patients. Aims: This study considered whether Integrated Dual Disorder Treatment (IDDT), developed and researched in the United States, could be implemented in the Netherlands. Method: Five outpatient teams participated in the pilot. American implementation materials were translated, treatment staff trained, dual disorder treatment implemented, and barriers to implementation and strategies to overcome these were considered. The progress of implementation of Integrated Dual Disorder Treatment was followed by fidelity measurements. Results: In the baseline measurement the teams had an average score of 2.2 (5 meaning full implementation). One year later, the average had increased to 3. At the end of the project the average sco...
{"title":"Systematic implementation of integrated dual disorders treatment in The Netherlands","authors":"A. V. Wamel, H. Kroon, S. V. Rooijen","doi":"10.1080/17523280902932649","DOIUrl":"https://doi.org/10.1080/17523280902932649","url":null,"abstract":"Background: In the Netherlands, mental illness and addiction are treated separately. This causes problems when treating dual disorders. There is growing consensus in the Netherlands that the integration of mental health care and addiction care may be the best way to treat dual disorder patients. Aims: This study considered whether Integrated Dual Disorder Treatment (IDDT), developed and researched in the United States, could be implemented in the Netherlands. Method: Five outpatient teams participated in the pilot. American implementation materials were translated, treatment staff trained, dual disorder treatment implemented, and barriers to implementation and strategies to overcome these were considered. The progress of implementation of Integrated Dual Disorder Treatment was followed by fidelity measurements. Results: In the baseline measurement the teams had an average score of 2.2 (5 meaning full implementation). One year later, the average had increased to 3. At the end of the project the average sco...","PeriodicalId":88592,"journal":{"name":"Mental health and substance use : dual diagnosis","volume":"76 1","pages":"101-110"},"PeriodicalIF":0.0,"publicationDate":"2009-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82098047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2009-06-02DOI: 10.1080/17523280902930114
S. Kaur, M. Daffern, Stuart D M Thomas
Background: Providing optimal treatment is pivotal to improved health and justice outcomes for patients with dual diagnosis. Unfortunately, the available evidence suggests that these patients may be unduly prejudiced during hospitalisation due to perceptions that their requests for pro re nata (PRN) medication is ‘drug-seeking’, reflecting persistent dependence or tendencies toward abuse of licit and illicit substances. Aims: To examine psychiatric nurses' responses to patients requests for PRN medication, to examine whether these requests are interpreted as ‘drug-seeking’, and to characterise patients described as such. Method: Case files and medication charts of patients diagnosed with schizophrenia admitted to a secure psychiatric service were reviewed to determine (a) their history of drug use, (b) the frequency with which they requested PRN medication, (c) how often staff administered PRN medication following request, and (d) how often patients were labelled ‘drug seeking’. Results: Patients with a h...
{"title":"Are patients with a history of illicit drug use perceived to be ‘drug-seeking’ when they request pro re nata medication and does this impact on its administration?","authors":"S. Kaur, M. Daffern, Stuart D M Thomas","doi":"10.1080/17523280902930114","DOIUrl":"https://doi.org/10.1080/17523280902930114","url":null,"abstract":"Background: Providing optimal treatment is pivotal to improved health and justice outcomes for patients with dual diagnosis. Unfortunately, the available evidence suggests that these patients may be unduly prejudiced during hospitalisation due to perceptions that their requests for pro re nata (PRN) medication is ‘drug-seeking’, reflecting persistent dependence or tendencies toward abuse of licit and illicit substances. Aims: To examine psychiatric nurses' responses to patients requests for PRN medication, to examine whether these requests are interpreted as ‘drug-seeking’, and to characterise patients described as such. Method: Case files and medication charts of patients diagnosed with schizophrenia admitted to a secure psychiatric service were reviewed to determine (a) their history of drug use, (b) the frequency with which they requested PRN medication, (c) how often staff administered PRN medication following request, and (d) how often patients were labelled ‘drug seeking’. Results: Patients with a h...","PeriodicalId":88592,"journal":{"name":"Mental health and substance use : dual diagnosis","volume":"29 1","pages":"111-119"},"PeriodicalIF":0.0,"publicationDate":"2009-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79075029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2009-06-02DOI: 10.1080/17523280902932631
Stewart Stubbs, L. Maher, Elizabeth O'Neil
Dual diagnosis is common among substance-using adolescent populations. Increasingly, young people are presenting to mental health and drug and alcohol service providers with dual diagnosis issues. Early intervention and treatment services are being researched and developed. However, there are few programmes established in the area of prevention. A comprehensive population health-based dual diagnosis prevention project incorporating community education, resource development, community awareness raising, and professional training was undertaken in Western Sydney, Australia. Evaluations demonstrated that a multifaceted strategy was effective in raising community awareness, generating help-seeking behaviour in individuals concerned about dual diagnosis, increasing knowledge and confidence of professionals working in the field, and establishing sustaining partnerships to extend the reach of the project beyond initial funding parameters. Potentially sensitive issues such as dual diagnosis and substance use can ...
{"title":"A report on the ‘Keep Your Head Together’ project: a dual diagnosis population health prevention initiative undertaken in Western Sydney, Australia","authors":"Stewart Stubbs, L. Maher, Elizabeth O'Neil","doi":"10.1080/17523280902932631","DOIUrl":"https://doi.org/10.1080/17523280902932631","url":null,"abstract":"Dual diagnosis is common among substance-using adolescent populations. Increasingly, young people are presenting to mental health and drug and alcohol service providers with dual diagnosis issues. Early intervention and treatment services are being researched and developed. However, there are few programmes established in the area of prevention. A comprehensive population health-based dual diagnosis prevention project incorporating community education, resource development, community awareness raising, and professional training was undertaken in Western Sydney, Australia. Evaluations demonstrated that a multifaceted strategy was effective in raising community awareness, generating help-seeking behaviour in individuals concerned about dual diagnosis, increasing knowledge and confidence of professionals working in the field, and establishing sustaining partnerships to extend the reach of the project beyond initial funding parameters. Potentially sensitive issues such as dual diagnosis and substance use can ...","PeriodicalId":88592,"journal":{"name":"Mental health and substance use : dual diagnosis","volume":"124 1","pages":"154-164"},"PeriodicalIF":0.0,"publicationDate":"2009-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87814308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2009-01-13DOI: 10.1080/17523280802593301
A. Hamdan-Mansour, J. Halabi, H. Dawani
Background: University students are a target population for a number of research studies due to a high prevalence of mental health and psychosocial problems. Aims: To examine the relationship between depressive symptoms, hostility, and substance use among university students in Jordan. Methods: This is a descriptive correlation study. Data were collected on demographics, depressive symptoms, hostility, and substance use from 572 university students in Jordan. Results: Almost 75% of the university students exhibited some degree of depressive symptoms. Tobacco, painkillers, stimulants, tranquilizers, inhalants, and alcohol respectively were the most used substances. Depressive symptoms were positively correlated with hostility and tobacco use. Similarly, depression had a positive correlation with the frequency of using painkillers, inhalants, stimulants, tranquilizers, and heroin. Male and female university students were not different in their depressive symptoms, hostility, and frequency of substance use. ...
{"title":"Depression, hostility, and substance use among university students in Jordan","authors":"A. Hamdan-Mansour, J. Halabi, H. Dawani","doi":"10.1080/17523280802593301","DOIUrl":"https://doi.org/10.1080/17523280802593301","url":null,"abstract":"Background: University students are a target population for a number of research studies due to a high prevalence of mental health and psychosocial problems. Aims: To examine the relationship between depressive symptoms, hostility, and substance use among university students in Jordan. Methods: This is a descriptive correlation study. Data were collected on demographics, depressive symptoms, hostility, and substance use from 572 university students in Jordan. Results: Almost 75% of the university students exhibited some degree of depressive symptoms. Tobacco, painkillers, stimulants, tranquilizers, inhalants, and alcohol respectively were the most used substances. Depressive symptoms were positively correlated with hostility and tobacco use. Similarly, depression had a positive correlation with the frequency of using painkillers, inhalants, stimulants, tranquilizers, and heroin. Male and female university students were not different in their depressive symptoms, hostility, and frequency of substance use. ...","PeriodicalId":88592,"journal":{"name":"Mental health and substance use : dual diagnosis","volume":"4 1","pages":"52-63"},"PeriodicalIF":0.0,"publicationDate":"2009-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83672914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2009-01-13DOI: 10.1080/17523280802593285
Kristy Johns, A. Baker, R. Webster, T. Lewin
Background: Retention in substance abuse treatment is difficult but essential for positive post-treatment outcomes. Aims: The present study is the first to explore factors related to retention in a long-term specialist residential substance abuse treatment programme for women in Australia. Methods: Archival data (e.g. socio-demographic, substance use, mental health, and length of stay) were collected from a sample of 71 women admitted to the programme between January 1997, and November 2002. Participants were divided into two groups based on their length of stay in the programme: less than 90 days (n = 42) and 90 days or more (n = 29). Results: A substantial proportion of the sample experienced comorbid substance abuse and mental health problems, with 60.6% (n = 43/71) reporting evidence of comorbidity (either a previous psychiatric diagnosis, or having been prescribed psychiatric medications). Overall, only 13% of residents completed the programme. Longer retention was associated with demographic (older ...
{"title":"Factors associated with retention in a long-term residential rehabilitation programme for women with substance use problems","authors":"Kristy Johns, A. Baker, R. Webster, T. Lewin","doi":"10.1080/17523280802593285","DOIUrl":"https://doi.org/10.1080/17523280802593285","url":null,"abstract":"Background: Retention in substance abuse treatment is difficult but essential for positive post-treatment outcomes. Aims: The present study is the first to explore factors related to retention in a long-term specialist residential substance abuse treatment programme for women in Australia. Methods: Archival data (e.g. socio-demographic, substance use, mental health, and length of stay) were collected from a sample of 71 women admitted to the programme between January 1997, and November 2002. Participants were divided into two groups based on their length of stay in the programme: less than 90 days (n = 42) and 90 days or more (n = 29). Results: A substantial proportion of the sample experienced comorbid substance abuse and mental health problems, with 60.6% (n = 43/71) reporting evidence of comorbidity (either a previous psychiatric diagnosis, or having been prescribed psychiatric medications). Overall, only 13% of residents completed the programme. Longer retention was associated with demographic (older ...","PeriodicalId":88592,"journal":{"name":"Mental health and substance use : dual diagnosis","volume":"105 1","pages":"40-51"},"PeriodicalIF":0.0,"publicationDate":"2009-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72923905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2009-01-13DOI: 10.1080/17523280802593293
L. Gregg, G. Haddock, C. Barrowclough
Background: Large numbers of people with a diagnosis of schizophrenia use drugs and alcohol, resulting in poorer symptomatic and functional outcomes for many. Aims: To examine the reasons that people with a diagnosis of schizophrenia give for their own alcohol and drug use. Method: Q methodology was used to examine reasons for use. Forty-five people with a diagnosis of schizophrenia or schizoaffective disorder and comorbid substance misuse completed the sorting procedure. Results: Analysis of the Q Sorts revealed three distinct groups of substance users: (1) those who predominantly used for social and enhancement reasons, to ‘chill out and have a good time with others:’ (2) those who used to regulate negative affect and alleviate positive symptoms, to ‘cope with distressing emotions and symptoms:’ (3) those who used substances to augment themselves and intensify their experiences, to ‘feel bigger, better and inspired.’ Conclusion: People with a diagnosis of schizophrenia who use substances explain their s...
{"title":"Self-reported reasons for substance use in schizophrenia: a Q methodological investigation","authors":"L. Gregg, G. Haddock, C. Barrowclough","doi":"10.1080/17523280802593293","DOIUrl":"https://doi.org/10.1080/17523280802593293","url":null,"abstract":"Background: Large numbers of people with a diagnosis of schizophrenia use drugs and alcohol, resulting in poorer symptomatic and functional outcomes for many. Aims: To examine the reasons that people with a diagnosis of schizophrenia give for their own alcohol and drug use. Method: Q methodology was used to examine reasons for use. Forty-five people with a diagnosis of schizophrenia or schizoaffective disorder and comorbid substance misuse completed the sorting procedure. Results: Analysis of the Q Sorts revealed three distinct groups of substance users: (1) those who predominantly used for social and enhancement reasons, to ‘chill out and have a good time with others:’ (2) those who used to regulate negative affect and alleviate positive symptoms, to ‘cope with distressing emotions and symptoms:’ (3) those who used substances to augment themselves and intensify their experiences, to ‘feel bigger, better and inspired.’ Conclusion: People with a diagnosis of schizophrenia who use substances explain their s...","PeriodicalId":88592,"journal":{"name":"Mental health and substance use : dual diagnosis","volume":"37 1","pages":"24-39"},"PeriodicalIF":0.0,"publicationDate":"2009-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89344527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2009-01-13DOI: 10.1080/17523280802630277
Richard Shrubb
Events leading to my breakdown. My view on recovery. Medical treatment, followed by the time to get over that treatment. That time should be used in preparing for life after care. Training, leading to employment – employment leading to life after being a psychiatric patient. My original intentions on being diagnosed with mental illness – recover, get a trade, get a job, get a life!’
{"title":"The fall and rise of Richard Shrubb","authors":"Richard Shrubb","doi":"10.1080/17523280802630277","DOIUrl":"https://doi.org/10.1080/17523280802630277","url":null,"abstract":"Events leading to my breakdown. My view on recovery. Medical treatment, followed by the time to get over that treatment. That time should be used in preparing for life after care. Training, leading to employment – employment leading to life after being a psychiatric patient. My original intentions on being diagnosed with mental illness – recover, get a trade, get a job, get a life!’","PeriodicalId":88592,"journal":{"name":"Mental health and substance use : dual diagnosis","volume":"181 1","pages":"8-12"},"PeriodicalIF":0.0,"publicationDate":"2009-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73303426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2009-01-13DOI: 10.1080/17523280802593327
Joelle C Ferron, A. Alterman, G. McHugo, M. Brunette, R. Drake
Background: Recent studies show that 75–85% of people with schizophrenia spectrum disorders in the United States smoke cigarettes, compared with 23% of the general population. Moreover, people with these illnesses on average have life expectancies 25 years lower than the general population, and smoking is a contributor. Aims: To review intervention research and evaluate the methods and clinical findings associated with attempts to eliminate, or reduce, smoking in people with schizophrenia spectrum disorders. Methods: PubMed and PsychInfo were searched from early 1990 through 2007 with select keywords. Thirteen treatment studies addressing smoking cessation interventions in people with schizophrenia spectrum disorders or severe mental illness were identified. Results: Nicotine replacement therapy, psychosocial interventions, and bupropion have been studied. Overall, treatment compliance was moderate, quit rates were low, and relapse to smoking was high. Modest evidence supports the efficacy of bupropion an...
{"title":"A review of research on smoking cessation interventions for adults with schizophrenia spectrum disorders","authors":"Joelle C Ferron, A. Alterman, G. McHugo, M. Brunette, R. Drake","doi":"10.1080/17523280802593327","DOIUrl":"https://doi.org/10.1080/17523280802593327","url":null,"abstract":"Background: Recent studies show that 75–85% of people with schizophrenia spectrum disorders in the United States smoke cigarettes, compared with 23% of the general population. Moreover, people with these illnesses on average have life expectancies 25 years lower than the general population, and smoking is a contributor. Aims: To review intervention research and evaluate the methods and clinical findings associated with attempts to eliminate, or reduce, smoking in people with schizophrenia spectrum disorders. Methods: PubMed and PsychInfo were searched from early 1990 through 2007 with select keywords. Thirteen treatment studies addressing smoking cessation interventions in people with schizophrenia spectrum disorders or severe mental illness were identified. Results: Nicotine replacement therapy, psychosocial interventions, and bupropion have been studied. Overall, treatment compliance was moderate, quit rates were low, and relapse to smoking was high. Modest evidence supports the efficacy of bupropion an...","PeriodicalId":88592,"journal":{"name":"Mental health and substance use : dual diagnosis","volume":"94 1","pages":"64-79"},"PeriodicalIF":0.0,"publicationDate":"2009-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76785174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：